- Home
- DAWN vs PRGO Comparison
DAWN vs PRGO Comparison
Compare DAWN & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- PRGO
- Stock Information
- Founded
- DAWN 2018
- PRGO 1887
- Country
- DAWN United States
- PRGO Ireland
- Employees
- DAWN N/A
- PRGO N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- DAWN Health Care
- PRGO Health Care
- Exchange
- DAWN Nasdaq
- PRGO Nasdaq
- Market Cap
- DAWN N/A
- PRGO 3.7B
- IPO Year
- DAWN 2021
- PRGO 1991
- Fundamental
- Price
- DAWN $6.80
- PRGO $27.20
- Analyst Decision
- DAWN Strong Buy
- PRGO Buy
- Analyst Count
- DAWN 7
- PRGO 3
- Target Price
- DAWN $31.57
- PRGO $33.00
- AVG Volume (30 Days)
- DAWN 1.3M
- PRGO 998.0K
- Earning Date
- DAWN 07-29-2025
- PRGO 08-01-2025
- Dividend Yield
- DAWN N/A
- PRGO 4.26%
- EPS Growth
- DAWN N/A
- PRGO N/A
- EPS
- DAWN N/A
- PRGO N/A
- Revenue
- DAWN $161,922,000.00
- PRGO $4,335,200,000.00
- Revenue This Year
- DAWN $17.98
- PRGO $3.24
- Revenue Next Year
- DAWN $49.50
- PRGO $2.15
- P/E Ratio
- DAWN N/A
- PRGO N/A
- Revenue Growth
- DAWN N/A
- PRGO N/A
- 52 Week Low
- DAWN $6.08
- PRGO $23.14
- 52 Week High
- DAWN $16.76
- PRGO $30.93
- Technical
- Relative Strength Index (RSI)
- DAWN 55.46
- PRGO 59.11
- Support Level
- DAWN $6.22
- PRGO $26.32
- Resistance Level
- DAWN $6.95
- PRGO $27.88
- Average True Range (ATR)
- DAWN 0.25
- PRGO 0.49
- MACD
- DAWN 0.04
- PRGO 0.07
- Stochastic Oscillator
- DAWN 80.11
- PRGO 72.16
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.